Inactive Instrument

PCAS Share Price

PCA

FR0000053514

PCAS specializes in developing, manufacturing, and marketing fine and specialty chemicals. Sales are distributed by family of products as follows: - synthesized pharmaceutical products (63.5%); - fine chemicals (36.5%): technical fluids and additives for the lubricant industry, chemical additive synthesis. The group also offers photochemical and new technology products (photosensitive materials, photo-initiators, and polymers for photography, reprography, and micro-electronics). At the end of 2022, the group had 7 production sites located in France (5), Canada and Finland. France accounts for 76% of net sales.

Employees

1,178

Sector

Pharmaceuticals

More about the company

The best tools reserved for subscribers to boost the performance of your investments!

09/02/24	Orapi: takeover bid reopens on February 12
02/02/24	Orapi: 3.15 million shares tendered to the takeover bid
22/12/23	Orapi: takeover bid opens on December 27
18/12/23	PCAS: 200 ME capital increase
03/11/23	PCAS: OPAS to start this Friday
24/10/23	PCAS Announces the Consolidated Net Sales Results for the Month of September 30, 2023	CI
16/10/23	Progyny, Inc. : Want to have a baby?
07/09/23	PCAS: Seqens launches minority share offer
05/09/23	PCAS SA Reports Earnings Results for the Half Year Ended June 30, 2023	CI
27/07/23	PCAS SA Reports Consolidated Sales Results for the Period Ended June 30, 2023	CI
31/05/23	DIC Corporation completed the acquisition of PCAS Canada Inc. from PCAS SA.	CI
25/05/23	PCAS: sale of Canadian subsidiary confirmed
25/05/23	PCAS to Divest Canadian Arm to Japan's DIC	MT

24/10/23	PCAS: Net Sales as of September 30, 2023	GL
06/09/23	PCAS: RESULTS AS OF JUNE 30, 2023	GL
27/07/23	Pcas: Net sales as of June 30, 2023	GL
25/05/23	PCAS to sell its Canadian subsidiary, PCAS Canada Inc., to DIC Corporation	GL
02/05/23	PCAS enters into exclusive negotiations with DIC Corporation following receipt of an offer for the acquisition of its Canadian subsidiary, PCAS Canada Inc.	GL

09/02/24	Orapi : l'OPA réouvre le 12 février
02/02/24	Orapi : 3,15 millions d'actions apportées à l'OPA
05/01/24	Progyny, Inc.: ¿Quieres tener un bebé?
22/12/23	Orapi : l'OPA démarre le 27 décembre
18/12/23	PCAS : augmentation de capital de 200 ME

Manager	Title	Age	Since
Gildas Barreyre CEO	Chief Executive Officer	43	02/05/2025
Eric Moissenot DFI	Director of Finance/CFO	-	-
Gérard Guillamot CTO	Chief Tech/Sci/R&D Officer	-	28/02/1999

Director	Title	Age	Since
Jacqueline Lecourtier BRD	Director/Board Member	74	28/02/2014
Janine Cossy BRD	Director/Board Member	-	-

PCAS Share Price

Stocks

PCA

FR0000053514

Pharmaceuticals

Latest news: PCAS

Press Releases: PCAS

News in other languages: PCAS

Managers and Directors: PCAS

Other Pharmaceuticals

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PCAS	-.--%	-.--%	-	-	125M
ELI LILLY AND COMPANY	+0.13%	+2.65%	+63.34%	+115.27%	1,055B
JOHNSON & JOHNSON	+0.20%	+0.46%	+50.92%	+72.63%	654B
ABBVIE INC.	-0.29%	+0.14%	+19.82%	+72.62%	467B
ROCHE HOLDING AG	+1.01%	-0.05%	+42.37%	+46.02%	348B
NOVARTIS AG	+1.64%	+4.77%	+22.85%	+29.85%	275B
ASTRAZENECA PLC	+0.23%	+0.22%	+13.53%	+14.37%	258B
AMGEN INC.	+2.11%	+7.51%	+51.88%	+54.14%	224B
GILEAD SCIENCES, INC.	+0.83%	+0.55%	+34.64%	+99.77%	187B
NOVO NORDISK A/S	+0.22%	-2.25%	-27.70%	-60.99%	171B
Average	+0.61%	+0.74%	+30.18%	+49.30%	404.26B
Weighted average by Cap.	+0.46%	+1.32%	+40.48%	+69.08%